Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices [NA]
A completed clinical trial evaluated the effectiveness of low-cost devices in improving patient adherence across multiple conditions. The up…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia [NA]
This clinical trial update reports a completed study evaluating Umooze as add-on therapy for Benign Prostatic Hyperplasia. Results were post…
-
FDA approval · 2015-12-23FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited, authorizing the generic finasteride product to be…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: EC905 Pharmacokinetic Profile Study [Phase 1]
Phase 1 pharmacokinetic study of EC905 completed, assessing pharmacokinetics in healthy volunteers and in Benign Prostatic Hyperplasia with …
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms [Phase 3]
A Phase 3 trial evaluating the combination of solifenacin succinate and tamsulosin hydrochloride OCAS in men with benign prostatic hyperplas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia [Phase 4]
Phase 4 trial assessing safety and efficacy of a fixed-dose combination of dutasteride and tamsulosin for six months in benign prostatic hyp…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy [Phase 3]
A Phase 3 study comparing finasteride (Proscar) to placebo in men with an enlarged prostate who had an initial negative biopsy; the trial ha…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2) [Phase 3]
Phase 3 trial comparing finasteride to tamsulosin for benign prostatic hyperplasia was terminated with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia [NA]
A completed clinical trial comparing the UroLift System to TURP for benign prostatic hyperplasia; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: UroLift System TOlerability and ReCovery When Administering Local Anesthesia [NA]
Clinical trial update on the UroLift system focusing on tolerability and recovery when administered with local anesthesia for benign prostat…
-
FDA approval · 2015-11-20FDA Approved: DUTASTERIDE — Original Application (Banyan Pharma LLC)
FDA approves Banyan Pharma LLC's generic dutasteride through an Original Application (ANDA).
-
FDA approval · 2015-11-20FDA Approved: DUTASTERIDE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original application for dutasteride as a generic version of Avodart.
-
FDA approval · 2015-11-20FDA Approved: DUTASTERIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's original abbreviated new drug application for dutasteride (generic) for use in benign prostatic hy…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation [Phase 4]
A Phase 4 study evaluated tolerability and efficacy of tamsulosin 0.4 mg OCAS in patients with LUTS due to benign prostatic hyperplasia who …
-
FDA approval · 2015-11-09FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for tamsulosin hydrochloride from Sun Pharmaceutical Industries, expanding/regulatory approval f…
-
FDA approval · 2015-10-30FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for tamsulosin hydrochloride from Sandoz Inc, updating the approval status for this generic product.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization [Phase 4]
A long-term Phase 4 trial evaluating photoselective vaporization for benign prostatic hyperplasia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia [NA]
This entry notes the completion of a Kaiser Permanente-sponsored clinical trial evaluating a self-administered maneuver to relieve symptoms …
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 post-marketing trial update for PROLIEVE in the treatment of Benign Prostatic Hyperplasia. Current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Postoperative Sleep Quality of Patients Sedation With i.v. Dexmedetomidine or Midazolam Undergoing TURP [Phase 4]
A Phase 4 trial comparing intravenous dexmedetomidine versus midazolam for postoperative sleep quality in patients undergoing transurethral …
-
FDA approval · 2015-09-16FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
The FDA approved Cialis (tadalafil) via a supplemental application submitted by Eli Lilly and Company. The approval updates the labeling and…
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada) [NA]
A Canadian clinical trial evaluating Vortx Rx for benign prostatic hyperplasia has been withdrawn, and safety/initial efficacy data will not…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: The Safety and Effectiveness of UroLift: LIFT Pivotal Study [NA]
Clinical trial update for the UroLift LIFT pivotal study in benign prostatic hyperplasia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. [Phase 3]
Phase 3 trial evaluating selective prostatic arterial embolization in men with benign prostatic hyperplasia who require an indwelling cathet…
-
CLINICAL_TRIALS research · 2015-07-14Clinical Trial Update: Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan [NA]
This document provides an update to the clinical protocol for Flowmed's Aqueduct Irrigation System medical device; no study results are repo…